These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35406631)

  • 1. Psoralen Suppresses Lipid Deposition by Alleviating Insulin Resistance and Promoting Autophagy in Oleate-Induced L02 Cells.
    Wang Y; Wang Y; Li F; Zou J; Li X; Xu M; Yu D; Ma Y; Huang W; Sun X; Zhang Y
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy].
    Shi YM; Fu ZH; Zhu CS; Li XP
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1770-1778. PubMed ID: 37282951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK.
    Yang Y; Wu Y; Zou J; Wang YH; Xu MX; Huang W; Yu DJ; Zhang L; Zhang YY; Sun XD
    Front Pharmacol; 2021; 12():687095. PubMed ID: 34163366
    [No Abstract]   [Full Text] [Related]  

  • 4. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK.
    Huang Q; Wang T; Yang L; Wang HY
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis.
    Cho W; Oh H; Abd El-Aty AM; Özten Ö; Jeong JH; Jung TW
    Biochem Biophys Res Commun; 2024 Apr; 703():149671. PubMed ID: 38367515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.
    Xiao Z; Chu Y; Qin W
    Life Sci; 2020 Sep; 256():117997. PubMed ID: 32585242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanin attenuates palmitate-induced hepatic lipid accumulation and insulin resistance via AMPK-mediated suppression of the mTOR pathway.
    Kwon C; Sun JL; Jeong JH; Jung TW
    Biochem Biophys Res Commun; 2020 May; 526(2):539-545. PubMed ID: 32245619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway.
    Xue W; Wang J; Jiang W; Shi C; Wang X; Huang Y; Hu C
    Eur J Pharmacol; 2020 Mar; 871():172910. PubMed ID: 31926991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pterostilbene alleviated NAFLD via AMPK/mTOR signaling pathways and autophagy by promoting Nrf2.
    Shen B; Wang Y; Cheng J; Peng Y; Zhang Q; Li Z; Zhao L; Deng X; Feng H
    Phytomedicine; 2023 Jan; 109():154561. PubMed ID: 36610156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress on AMPK activation in nonalcoholic fatty liver disease].
    Ye XY; Li TX; Huang ZW; Fu WW; Li Q
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1220-1223. PubMed ID: 38238958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress.
    Park SY; Cho W; Abd El-Aty AM; Hacimuftuoglu A; Jeong JH; Jung TW
    Biochem Pharmacol; 2022 May; 199():115022. PubMed ID: 35358477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis via the LKB1-AMPK-mTOR Pathway.
    Liang Y; Zhang Z; Tu J; Wang Z; Gao X; Deng K; El-Samahy MA; You P; Fan Y; Wang F
    J Agric Food Chem; 2021 Jul; 69(29):8257-8267. PubMed ID: 34281337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway.
    Xu N; Luo H; Li M; Wu J; Wu X; Chen L; Gan Y; Guan F; Li M; Su Z; Chen J; Liu Y
    Biomed Pharmacother; 2021 Feb; 134():111104. PubMed ID: 33341045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4-With improving insulin resistance.
    Peng CH; Ker YB; Li HH; Tsou SH; Lin CL; Huang CN
    PLoS One; 2022; 17(3):e0265444. PubMed ID: 35290413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene.
    Zhao ZH; Wang ZX; Zhou D; Han Y; Ma F; Hu Z; Xin FZ; Liu XL; Ren TY; Zhang F; Xue Y; Cui A; Liu Z; Bai J; Liu Y; Cai G; Su W; Dai X; Shen F; Pan Q; Li Y; Fan JG
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):857-871. PubMed ID: 33989817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.